Rinvoq LQ 1 mg/mL oral solution Images
Generic Name: upadacitinib
This medication has been identified as Rinvoq LQ 1 mg/mL oral solution. It is supplied by AbbVie Inc.
Rinvoq LQ is used in the treatment of Polyarticular Juvenile Idiopathic Arthritis; Psoriatic Arthritis and belongs to the drug class antirheumatics. Rinvoq LQ 1 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rinvoq LQ
- Generic Name
- upadacitinib
- Strength
- 1 mg/mL oral solution
- Availability
- Prescription only
- Drug Class
- Antirheumatics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-2320
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
More about Rinvoq LQ (upadacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antirheumatics
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.